Outcome and Risk Factors For Mortality in Peritoneal Dialysis Patients: 20 Years Experience in a Single Turkish Center
Sponsored by Istanbul University
About this trial
Last updated 9 years ago
Study ID
252
Status
Completed
Type
Observational
Placebo
No
Accepting
18 to 75 Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 10 years ago
What is this trial about?
INTRODUCTION AND AIMS: The aims of this study were to evaluate patient and technique survival
rates, investigate peritonitis rates and evaluate factors affecting mortality in peritoneal
dialysis (PD) patients over a period of 20 years at Istanbul Faculty of Medicine Peritoneal
Dialysis Unit.
METHODS: Two hundred seventy seven patients have received PD as renal replacement therapy
(RRT) over a period of 20 years. After exclusion of patients with follow-up shorter than 3
months and patients whose data were not available, 250 patients were examined
retrospectively. Data for sex, age, primary disease, comorbidities, follow up duration, cause
of death, and cause of technique failure were collected from medical records.
What are the participation requirements?
Inclusion Criteria
- all patients 18 years of age and older
- treated with PD at the Istanbul Medical Faculty from October 1994 to October 2014
Exclusion Criteria
- follow-up shorter than 3 months and patients whose data were not available,
- data were not available
- patients who were unwilling
- patients who unable to provide informed consent